Deomion raises seed funding from AI Angel Club, CNT Tech, and People Investment
Summary
Deomion raised a seed round from AI Angel Club, CNT Tech, and People Investment, with AI Angel Club leading the deal. The company develops NADS, a transdermal drug delivery platform that forms nano-particles without additives or physical stimulation. Deomion plans to first commercialize dermocosmetic ingredients and veterinary topical medicines before expanding into human drug development. The company says the new funding and a government R&D program will help it launch products, build clinical data, and prepare for future human therapeutics.
Funding
Amount
-
Total raised
Date
September 2, 2026
Announcement date
Investors
-
Lead investors
Company
-
Funded company
AskAI Classifications
Sectors
No sectors detected
Functions
No functions detected